These results collectively suggest that HIF-1α can promote the malignant progression of GBM by activating the P-PI3K/P-AKT, SOX2/OCT4, and MMP2/MMP9 signaling pathways both in vivo and in vitro. The gene discussed is HIF1A; the disease is glioblastoma.